When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs's words, a huge part of what Yosemite does. "I didn't expect Yosemite to be moving this fast," he said.
I've always been the gamer in the family. When my son was born nearly 11 years ago, gaming was one of the things I looked forward to sharing with him. Pulling up a chair next to me, he would watch as I played Sea of Thieves with friends, often wearing the too-big-for-his-head headset to talk […]
Apple's self-driving car program never really got off the ground, but it may have been what made the company's chips the powerful AI performers they are. Early in the development of the self-driving platform, Apple realized that it would need powerful on-device AI processing. While the car processor was never finished, as Mark Gurman details […]
